DF
Therapeutic Areas
selectION Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| si-544 | Psoriasis Vulgaris, Atopic Dermatitis, and other T cell-mediated autoimmune diseases | Phase 2 (planning) |
| Drug | Indication | Phase |
|---|---|---|
| si-544 | Psoriasis Vulgaris, Atopic Dermatitis, and other T cell-mediated autoimmune diseases | Phase 2 (planning) |